Mitchell A Olman Selected Research

Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)

10/2003

The pattern of enhancement of Src kinase activity on platelet-derived growth factor stimulation of glioblastoma cells is affected by the integrin engaged.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mitchell A Olman Research Topics

Disease

7	Acute Lung Injury 01/2020 - 03/2002
6	Fibrosis (Cirrhosis) 11/2019 - 09/2003
4	Idiopathic Pulmonary Fibrosis 03/2020 - 05/2010
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2017 - 07/2009
4	Pulmonary Edema 01/2008 - 03/2002
3	Neoplasms (Cancer) 01/2017 - 10/2003
2	Asthma (Bronchial Asthma) 01/2021 - 01/2017
2	Inflammation (Inflammations) 01/2020 - 03/2002
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020 - 01/2017
2	Lung Injury 01/2016 - 02/2004
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2015 - 01/2013
2	Glioblastoma (Glioblastoma Multiforme) 01/2011 - 10/2003
1	Respiratory Syncytial Virus Infections 01/2021
1	Septic Shock (Toxic Shock Syndrome) 01/2020
1	Infections 01/2020
1	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2019
1	Weight Loss (Weight Reduction) 12/2019
1	Venous Thromboembolism 01/2018
1	Cystic Fibrosis (Mucoviscidosis) 01/2017
1	Cicatrix (Scar) 01/2015
1	Edema (Dropsy) 07/2003

Drug/Important Bio-Agent (IBA)

3	CationsIBA 01/2020 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2011
2	CytokinesIBA 01/2020 - 01/2017
2	Pharmaceutical PreparationsIBA 01/2017 - 01/2013
2	Focal Adhesion Protein-Tyrosine KinasesIBA 05/2013 - 05/2010
2	Small Interfering RNA (siRNA)IBA 01/2011 - 10/2003
2	Phosphotransferases (Kinase)IBA 05/2010 - 10/2003
2	Transforming Growth Factor beta (TGF-beta)IBA 12/2009 - 09/2003
2	ProstaglandinsIBA 12/2009 - 01/2008
1	Nerve Growth Factor (NGF)IBA 01/2021
1	CalciumIBA 01/2021
1	Metalloproteases (Metalloproteinases)IBA 03/2020
1	Matrix Metalloproteinases (MMPs)IBA 03/2020
1	CatecholaminesIBA 01/2020
1	Biological ProductsIBA 01/2020
1	Vasopressins (Vasopressin)IBA 01/2020
1	Dual Specificity Phosphatase 1IBA 01/2020
1	pirfenidoneIBA 12/2019
1	nintedanibIBA 12/2019
1	cyclopropapyrroloindoleIBA 12/2019
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	Ion Channels (Ion Channel)IBA 01/2016
1	Macrophage Migration-Inhibitory FactorsIBA 01/2015
1	AnticoagulantsIBA 02/2014
1	FAK-related nonkinaseIBA 05/2013
1	Ethanol (Ethyl Alcohol)IBA 01/2013
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2013
1	Adenosine (Adenocard)FDA LinkGeneric 01/2013
1	Warfarin (Coumadin)FDA LinkGeneric 07/2012
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 05/2010
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 07/2009
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2008
1	Messenger RNA (mRNA)IBA 01/2008
1	Dinoprostone (PGE2)FDA Link 01/2008
1	Biomarkers (Surrogate Marker)IBA 10/2006
1	Interleukin-1beta (Interleukin 1 beta)IBA 02/2004
1	Interleukin-6 (Interleukin 6)IBA 02/2004
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 10/2003
1	IntegrinsIBA 10/2003
1	Integrin alpha ChainsIBA 10/2003
1	Integrin alphaVbeta3IBA 10/2003
1	integrin alphaVbeta5IBA 10/2003
1	Laminin (Merosin)IBA 10/2003
1	src-Family KinasesIBA 10/2003
1	VitronectinIBA 10/2003
1	CollagenIBA 10/2003
1	Platelet-Derived Growth FactorIBA 10/2003
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2003
1	Plasminogen Activator Inhibitor 1IBA 07/2003
1	Plasminogen Activators (Plasminogen Activator)IBA 07/2003
1	AntigensIBA 07/2003
1	MitogensIBA 03/2002
1	Interleukin-1 (Interleukin 1)IBA 03/2002

Therapy/Procedure

3	Therapeutics 12/2019 - 02/2014
1	Lung Transplantation 01/2018